​
​

Pharming Group Ownership 2024 | Who Owns Pharming Group Now?

OverviewRevenueFinancialsChartTranscripts

Institutional Ownership

0.04%

0

Institutional Holders

4.00

Pharming Group Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC0.03%0.19%23,4355,72532.33%195,682Jun 30, 2024
MORGAN STANLEY0.00%-2,800--23,380Jun 30, 2024
UBS GROUP AG0.00%-7897371417.31%6,588Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-568568100.00%4,743Jun 30, 2024

Pharming Group's largest institutional shareholder is SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC, holding 0.03% of the company's total share outstanding, currently valued at $195.68K. The top 10 institutional shareholders own together 0.04% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC0.03%0.19%23,4355,72532.33%195,682Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-568568100.00%4,743Jun 30, 2024
MORGAN STANLEY0.00%-2,800--23,380Jun 30, 2024
UBS GROUP AG0.00%-7897371417.31%6,588Jun 30, 2024

The largest Pharming Group shareholder by % of total assets is SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC. The company owns 23.43K shares of Pharming Group (PHAR), representing 0.19% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC0.03%0.19%23,4355,72532.33%195,682Jun 30, 2024
UBS GROUP AG0.00%-7897371417.31%6,588Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-568568100.00%4,743Jun 30, 2024
MORGAN STANLEY0.00%-2,800--23,380Jun 30, 2024

As of Jun 30 2024, Pharming Group's largest institutional buyer is SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC. The company purchased 5.72K stocks of PHAR, valued at $195.68K.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MORGAN STANLEY0.00%-2,800--23,380Jun 30, 2024
ADVISOR GROUP HOLDINGS, INC.0.00%-568568100.00%4,743Jun 30, 2024
UBS GROUP AG0.00%-7897371417.31%6,588Jun 30, 2024
SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC0.03%0.19%23,4355,72532.33%195,682Jun 30, 2024

As of Jun 30 2024, Pharming Group's biggest institutional seller is MORGAN STANLEY. The company sold 0.00 shares of PHAR, valued at $23.38K.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ADVISOR GROUP HOLDINGS, INC.0.00%-568568100.00%4,743Jun 30, 2024

Pharming Group's largest new institutional shareholder by number of shares is ADVISOR GROUP HOLDINGS, INC., purchased 568.00 shares, valued at $4.74K, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Pharming Group Mutual Fund Holders

Name% Total AssetsTotal SharesChange AmountChange %Date
TEMPLETON GLOBAL INVESTMENT TRUST0.00%297,837--Feb 29, 2024
FIDELITY CONCORD STREET TRUST0.00%2,093--Feb 29, 2024

Pharming Group's largest mutual fund holder by % of total assets is "TEMPLETON GLOBAL INVESTMENT TRUST", owning 297.84K shares, compromising 0.00% of its total assets.

Pharming Group Institutional Ownership Trends

Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24433.33%
31 Mar, 24350.00%
31 Dec, 232-
30 Sep, 232-
30 Jun, 232-33.33%
31 Mar, 233-
31 Dec, 223-
30 Sep, 223-
30 Jun, 223-25.00%
31 Mar, 22433.33%
31 Dec, 213-25.00%
30 Sep, 214-42.86%
30 Jun, 217133.33%
31 Mar, 21350.00%
31 Dec, 202-
30 Jun, 201-

As of 30 Jun 24, 4 institutions are holding Pharming Group's shares, representing an increase of 33.33% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2427,59234.19%
31 Mar, 2420,5620.25%
31 Dec, 2320,51044.28%
30 Sep, 2314,215-43.05%
30 Jun, 2324,960-3.41%
31 Mar, 2325,841-12.43%
31 Dec, 2229,51018.12%
30 Sep, 2224,98422.04%
30 Jun, 2220,472-0.55%
31 Mar, 2220,58610.51%
31 Dec, 2118,628-29.45%
30 Sep, 2126,403-86.70%
30 Jun, 21198,4553.28%
31 Mar, 21192,149-89.87%
31 Dec, 201,896,857-
30 Jun, 2016,500-

Pharming Group (PHAR) has 27.59K shares outstanding as of 30 Jun 24, up 34.19% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 240.04%4385.29%
31 Mar, 240.03%3291.48%
31 Dec, 230.03%6805.66%
30 Sep, 230.02%1403.35%
30 Jun, 230.04%2402.74%
31 Mar, 230.04%2214.55%
31 Dec, 220.04%3272.02%
30 Sep, 220.04%4122.97%
30 Jun, 220.03%3348.48%
31 Mar, 220.03%3534.48%
31 Dec, 210.03%1709.71%
30 Sep, 210.04%42.96%
30 Jun, 210.31%344.50%
31 Mar, 210.30%3.41%
31 Dec, 202.96%-
30 Jun, 200.03%-

As of 30 Jun 24, Pharming Group is held by 0.04% institutional shareholders, representing a 4385.29% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 243200.00%
31 Mar, 241-50.00%
31 Dec, 232100.00%
30 Sep, 231-
30 Jun, 23--100.00%
31 Mar, 231-
31 Dec, 221-66.67%
30 Sep, 22350.00%
30 Jun, 222-
31 Mar, 222-
31 Dec, 212100.00%
30 Sep, 211-80.00%
30 Jun, 215150.00%
31 Mar, 212-
31 Dec, 202-
30 Jun, 201-

3 institutional shareholders have increased their position in PHAR stock as of 30 Jun 24 compared to 1 in the previous quarter (a 200.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 24--
31 Mar, 24--
31 Dec, 23--
30 Sep, 23--
30 Jun, 23--100.00%
31 Mar, 232-
31 Dec, 222-
30 Sep, 22--
30 Jun, 22--100.00%
31 Mar, 221-
31 Dec, 211-
30 Sep, 211-50.00%
30 Jun, 212100.00%
31 Mar, 211-
31 Dec, 20--
30 Jun, 20--

- institutional shareholders have reduced their position in PHAR stock as of 30 Jun 24 compared to - in the previous quarter (a 0.00% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24433.33%27,59234.19%0.04%4385.29%3200.00%--
31 Mar, 24350.00%20,5620.25%0.03%3291.48%1-50.00%--
31 Dec, 232-20,51044.28%0.03%6805.66%2100.00%--
30 Sep, 232-14,215-43.05%0.02%1403.35%1---
30 Jun, 232-33.33%24,960-3.41%0.04%2402.74%--100.00%--100.00%
31 Mar, 233-25,841-12.43%0.04%2214.55%1-2-
31 Dec, 223-29,51018.12%0.04%3272.02%1-66.67%2-
30 Sep, 223-24,98422.04%0.04%4122.97%350.00%--
30 Jun, 223-25.00%20,472-0.55%0.03%3348.48%2---100.00%
31 Mar, 22433.33%20,58610.51%0.03%3534.48%2-1-
31 Dec, 213-25.00%18,628-29.45%0.03%1709.71%2100.00%1-
30 Sep, 214-42.86%26,403-86.70%0.04%42.96%1-80.00%1-50.00%
30 Jun, 217133.33%198,4553.28%0.31%344.50%5150.00%2100.00%
31 Mar, 21350.00%192,149-89.87%0.30%3.41%2-1-
31 Dec, 202-1,896,857-2.96%-2---
30 Jun, 201-16,500-0.03%-1---

Pharming Group Insider Shareholders Trades

Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 12, 2004CAMDEN PARTNERS STRATEGIC FUND II A LPother See General Remarks and FN 1A-AwardBuy5,000$0.68$3.40K5,000

Pharming Group Insider Ownership Trends

All Insider Trades Trend

DateBuySellBuy/Sell Ratio

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio

Pharming Group Peer Ownership

TickerCompany
PRTCPureTech Health plc
LRMRLarimar Therapeutics, Inc.
MLYSMineralys Therapeutics, Inc.
ACRVAcrivon Therapeutics, Inc. Common Stock
FENCFennec Pharmaceuticals Inc.
LIANLianBio
JANXJanux Therapeutics, Inc.
RZLTRezolute, Inc.
GNTAGenenta Science S.p.A.
ANEBAnebulo Pharmaceuticals, Inc.
MOLNMolecular Partners AG
VRCAVerrica Pharmaceuticals Inc.
FIXXQ32 Bio Inc.
PRDSPardes Biosciences, Inc.
OPTOpthea Limited
ELYMEliem Therapeutics, Inc.

PHAR Ownership FAQ

Pharming Group is owned by institutional shareholders (0.04%), insiders (0.00%), and public (99.96%). The largest institutional shareholder of Pharming Group is SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC (0.03% of total shares) and the top mutual fund owner is TEMPLETON GLOBAL INVESTMENT TRUST (0.00% of total shares).

Pharming Group's major institutional shareholders are SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC, MORGAN STANLEY, UBS GROUP AG, and ADVISOR GROUP HOLDINGS, INC.. The top five shareholders own together 0.04% of the company's share outstanding.

As of Jun 2024, there are 4 institutional shareholders of Pharming Group.

SILVERBERG BERNSTEIN CAPITAL MANAGEMENT LLC owns 23.44K shares of Pharming Group, representing 0.03% of the company's total shares outstanding, valued at $195.68K (as of Jun 2024).

As of Jun 2024, MORGAN STANLEY holds 2.8K shares of Pharming Group (PHAR), compromising 0.00% of the company, valued at $23.38K.

UBS GROUP AG is the third largest holder of Pharming Group. The company owns 789 of the company's shares outstanding (worth $6.59K).